Endovascular Abdominal Aortic Aneurysm Repair Devices
This report aims to provide a comprehensive presentation of the global market for Endovascular Ab ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Endometriosis Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 Hormonal Therapy 1.2.3 Add-back Medication 1.2.4 Progestogens 1.2.5 Chinese Herbs 1.3 Market by Application 1.3.1 Global Endometriosis Drugs Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Research Institutes 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Endometriosis Drugs Market Perspective (2018-2029) 2.2 Endometriosis Drugs Growth Trends by Region 2.2.1 Global Endometriosis Drugs Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Endometriosis Drugs Historic Market Size by Region (2018-2023) 2.2.3 Endometriosis Drugs Forecasted Market Size by Region (2024-2029) 2.3 Endometriosis Drugs Market Dynamics 2.3.1 Endometriosis Drugs Industry Trends 2.3.2 Endometriosis Drugs Market Drivers 2.3.3 Endometriosis Drugs Market Challenges 2.3.4 Endometriosis Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Endometriosis Drugs Players by Revenue 3.1.1 Global Top Endometriosis Drugs Players by Revenue (2018-2023) 3.1.2 Global Endometriosis Drugs Revenue Market Share by Players (2018-2023) 3.2 Global Endometriosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Endometriosis Drugs Revenue 3.4 Global Endometriosis Drugs Market Concentration Ratio 3.4.1 Global Endometriosis Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Endometriosis Drugs Revenue in 2022 3.5 Endometriosis Drugs Key Players Head office and Area Served 3.6 Key Players Endometriosis Drugs Product Solution and Service 3.7 Date of Enter into Endometriosis Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Endometriosis Drugs Breakdown Data by Type 4.1 Global Endometriosis Drugs Historic Market Size by Type (2018-2023) 4.2 Global Endometriosis Drugs Forecasted Market Size by Type (2024-2029) 5 Endometriosis Drugs Breakdown Data by Application 5.1 Global Endometriosis Drugs Historic Market Size by Application (2018-2023) 5.2 Global Endometriosis Drugs Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Endometriosis Drugs Market Size (2018-2029) 6.2 North America Endometriosis Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Endometriosis Drugs Market Size by Country (2018-2023) 6.4 North America Endometriosis Drugs Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Endometriosis Drugs Market Size (2018-2029) 7.2 Europe Endometriosis Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Endometriosis Drugs Market Size by Country (2018-2023) 7.4 Europe Endometriosis Drugs Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Endometriosis Drugs Market Size (2018-2029) 8.2 Asia-Pacific Endometriosis Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Endometriosis Drugs Market Size by Region (2018-2023) 8.4 Asia-Pacific Endometriosis Drugs Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Endometriosis Drugs Market Size (2018-2029) 9.2 Latin America Endometriosis Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Endometriosis Drugs Market Size by Country (2018-2023) 9.4 Latin America Endometriosis Drugs Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Endometriosis Drugs Market Size (2018-2029) 10.2 Middle East & Africa Endometriosis Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Endometriosis Drugs Market Size by Country (2018-2023) 10.4 Middle East & Africa Endometriosis Drugs Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 AbbVie 11.1.1 AbbVie Company Detail 11.1.2 AbbVie Business Overview 11.1.3 AbbVie Endometriosis Drugs Introduction 11.1.4 AbbVie Revenue in Endometriosis Drugs Business (2018-2023) 11.1.5 AbbVie Recent Development 11.2 Astellas Pharma 11.2.1 Astellas Pharma Company Detail 11.2.2 Astellas Pharma Business Overview 11.2.3 Astellas Pharma Endometriosis Drugs Introduction 11.2.4 Astellas Pharma Revenue in Endometriosis Drugs Business (2018-2023) 11.2.5 Astellas Pharma Recent Development 11.3 AstraZeneca 11.3.1 AstraZeneca Company Detail 11.3.2 AstraZeneca Business Overview 11.3.3 AstraZeneca Endometriosis Drugs Introduction 11.3.4 AstraZeneca Revenue in Endometriosis Drugs Business (2018-2023) 11.3.5 AstraZeneca Recent Development 11.4 Debiopharm Group 11.4.1 Debiopharm Group Company Detail 11.4.2 Debiopharm Group Business Overview 11.4.3 Debiopharm Group Endometriosis Drugs Introduction 11.4.4 Debiopharm Group Revenue in Endometriosis Drugs Business (2018-2023) 11.4.5 Debiopharm Group Recent Development 11.5 Evotec 11.5.1 Evotec Company Detail 11.5.2 Evotec Business Overview 11.5.3 Evotec Endometriosis Drugs Introduction 11.5.4 Evotec Revenue in Endometriosis Drugs Business (2018-2023) 11.5.5 Evotec Recent Development 11.6 Kissei Pharmaceutical 11.6.1 Kissei Pharmaceutical Company Detail 11.6.2 Kissei Pharmaceutical Business Overview 11.6.3 Kissei Pharmaceutical Endometriosis Drugs Introduction 11.6.4 Kissei Pharmaceutical Revenue in Endometriosis Drugs Business (2018-2023) 11.6.5 Kissei Pharmaceutical Recent Development 11.7 Neurocrine Biosciences 11.7.1 Neurocrine Biosciences Company Detail 11.7.2 Neurocrine Biosciences Business Overview 11.7.3 Neurocrine Biosciences Endometriosis Drugs Introduction 11.7.4 Neurocrine Biosciences Revenue in Endometriosis Drugs Business (2018-2023) 11.7.5 Neurocrine Biosciences Recent Development 11.8 ObsEva 11.8.1 ObsEva Company Detail 11.8.2 ObsEva Business Overview 11.8.3 ObsEva Endometriosis Drugs Introduction 11.8.4 ObsEva Revenue in Endometriosis Drugs Business (2018-2023) 11.8.5 ObsEva Recent Development 11.9 Pfizer 11.9.1 Pfizer Company Detail 11.9.2 Pfizer Business Overview 11.9.3 Pfizer Endometriosis Drugs Introduction 11.9.4 Pfizer Revenue in Endometriosis Drugs Business (2018-2023) 11.9.5 Pfizer Recent Development 11.10 Repros Therapeutics 11.10.1 Repros Therapeutics Company Detail 11.10.2 Repros Therapeutics Business Overview 11.10.3 Repros Therapeutics Endometriosis Drugs Introduction 11.10.4 Repros Therapeutics Revenue in Endometriosis Drugs Business (2018-2023) 11.10.5 Repros Therapeutics Recent Development 11.11 Roivant Sciences 11.11.1 Roivant Sciences Company Detail 11.11.2 Roivant Sciences Business Overview 11.11.3 Roivant Sciences Endometriosis Drugs Introduction 11.11.4 Roivant Sciences Revenue in Endometriosis Drugs Business (2018-2023) 11.11.5 Roivant Sciences Recent Development 11.12 Takeda Pharmaceutical Company 11.12.1 Takeda Pharmaceutical Company Company Detail 11.12.2 Takeda Pharmaceutical Company Business Overview 11.12.3 Takeda Pharmaceutical Company Endometriosis Drugs Introduction 11.12.4 Takeda Pharmaceutical Company Revenue in Endometriosis Drugs Business (2018-2023) 11.12.5 Takeda Pharmaceutical Company Recent Development 11.13 ValiRx 11.13.1 ValiRx Company Detail 11.13.2 ValiRx Business Overview 11.13.3 ValiRx Endometriosis Drugs Introduction 11.13.4 ValiRx Revenue in Endometriosis Drugs Business (2018-2023) 11.13.5 ValiRx Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Endometriosis Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of Hormonal Therapy Table 3. Key Players of Add-back Medication Table 4. Key Players of Progestogens Table 5. Key Players of Chinese Herbs Table 6. Global Endometriosis Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 7. Global Endometriosis Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 8. Global Endometriosis Drugs Market Size by Region (2018-2023) & (US$ Million) Table 9. Global Endometriosis Drugs Market Share by Region (2018-2023) Table 10. Global Endometriosis Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 11. Global Endometriosis Drugs Market Share by Region (2024-2029) Table 12. Endometriosis Drugs Market Trends Table 13. Endometriosis Drugs Market Drivers Table 14. Endometriosis Drugs Market Challenges Table 15. Endometriosis Drugs Market Restraints Table 16. Global Endometriosis Drugs Revenue by Players (2018-2023) & (US$ Million) Table 17. Global Endometriosis Drugs Market Share by Players (2018-2023) Table 18. Global Top Endometriosis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endometriosis Drugs as of 2022) Table 19. Ranking of Global Top Endometriosis Drugs Companies by Revenue (US$ Million) in 2022 Table 20. Global 5 Largest Players Market Share by Endometriosis Drugs Revenue (CR5 and HHI) & (2018-2023) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Endometriosis Drugs Product Solution and Service Table 23. Date of Enter into Endometriosis Drugs Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Endometriosis Drugs Market Size by Type (2018-2023) & (US$ Million) Table 26. Global Endometriosis Drugs Revenue Market Share by Type (2018-2023) Table 27. Global Endometriosis Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 28. Global Endometriosis Drugs Revenue Market Share by Type (2024-2029) Table 29. Global Endometriosis Drugs Market Size by Application (2018-2023) & (US$ Million) Table 30. Global Endometriosis Drugs Revenue Market Share by Application (2018-2023) Table 31. Global Endometriosis Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 32. Global Endometriosis Drugs Revenue Market Share by Application (2024-2029) Table 33. North America Endometriosis Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 34. North America Endometriosis Drugs Market Size by Country (2018-2023) & (US$ Million) Table 35. North America Endometriosis Drugs Market Size by Country (2024-2029) & (US$ Million) Table 36. Europe Endometriosis Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 37. Europe Endometriosis Drugs Market Size by Country (2018-2023) & (US$ Million) Table 38. Europe Endometriosis Drugs Market Size by Country (2024-2029) & (US$ Million) Table 39. Asia-Pacific Endometriosis Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 40. Asia-Pacific Endometriosis Drugs Market Size by Region (2018-2023) & (US$ Million) Table 41. Asia-Pacific Endometriosis Drugs Market Size by Region (2024-2029) & (US$ Million) Table 42. Latin America Endometriosis Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 43. Latin America Endometriosis Drugs Market Size by Country (2018-2023) & (US$ Million) Table 44. Latin America Endometriosis Drugs Market Size by Country (2024-2029) & (US$ Million) Table 45. Middle East & Africa Endometriosis Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 46. Middle East & Africa Endometriosis Drugs Market Size by Country (2018-2023) & (US$ Million) Table 47. Middle East & Africa Endometriosis Drugs Market Size by Country (2024-2029) & (US$ Million) Table 48. AbbVie Company Detail Table 49. AbbVie Business Overview Table 50. AbbVie Endometriosis Drugs Product Table 51. AbbVie Revenue in Endometriosis Drugs Business (2018-2023) & (US$ Million) Table 52. AbbVie Recent Development Table 53. Astellas Pharma Company Detail Table 54. Astellas Pharma Business Overview Table 55. Astellas Pharma Endometriosis Drugs Product Table 56. Astellas Pharma Revenue in Endometriosis Drugs Business (2018-2023) & (US$ Million) Table 57. Astellas Pharma Recent Development Table 58. AstraZeneca Company Detail Table 59. AstraZeneca Business Overview Table 60. AstraZeneca Endometriosis Drugs Product Table 61. AstraZeneca Revenue in Endometriosis Drugs Business (2018-2023) & (US$ Million) Table 62. AstraZeneca Recent Development Table 63. Debiopharm Group Company Detail Table 64. Debiopharm Group Business Overview Table 65. Debiopharm Group Endometriosis Drugs Product Table 66. Debiopharm Group Revenue in Endometriosis Drugs Business (2018-2023) & (US$ Million) Table 67. Debiopharm Group Recent Development Table 68. Evotec Company Detail Table 69. Evotec Business Overview Table 70. Evotec Endometriosis Drugs Product Table 71. Evotec Revenue in Endometriosis Drugs Business (2018-2023) & (US$ Million) Table 72. Evotec Recent Development Table 73. Kissei Pharmaceutical Company Detail Table 74. Kissei Pharmaceutical Business Overview Table 75. Kissei Pharmaceutical Endometriosis Drugs Product Table 76. Kissei Pharmaceutical Revenue in Endometriosis Drugs Business (2018-2023) & (US$ Million) Table 77. Kissei Pharmaceutical Recent Development Table 78. Neurocrine Biosciences Company Detail Table 79. Neurocrine Biosciences Business Overview Table 80. Neurocrine Biosciences Endometriosis Drugs Product Table 81. Neurocrine Biosciences Revenue in Endometriosis Drugs Business (2018-2023) & (US$ Million) Table 82. Neurocrine Biosciences Recent Development Table 83. ObsEva Company Detail Table 84. ObsEva Business Overview Table 85. ObsEva Endometriosis Drugs Product Table 86. ObsEva Revenue in Endometriosis Drugs Business (2018-2023) & (US$ Million) Table 87. ObsEva Recent Development Table 88. Pfizer Company Detail Table 89. Pfizer Business Overview Table 90. Pfizer Endometriosis Drugs Product Table 91. Pfizer Revenue in Endometriosis Drugs Business (2018-2023) & (US$ Million) Table 92. Pfizer Recent Development Table 93. Repros Therapeutics Company Detail Table 94. Repros Therapeutics Business Overview Table 95. Repros Therapeutics Endometriosis Drugs Product Table 96. Repros Therapeutics Revenue in Endometriosis Drugs Business (2018-2023) & (US$ Million) Table 97. Repros Therapeutics Recent Development Table 98. Roivant Sciences Company Detail Table 99. Roivant Sciences Business Overview Table 100. Roivant Sciences Endometriosis Drugs Product Table 101. Roivant Sciences Revenue in Endometriosis Drugs Business (2018-2023) & (US$ Million) Table 102. Roivant Sciences Recent Development Table 103. Takeda Pharmaceutical Company Company Detail Table 104. Takeda Pharmaceutical Company Business Overview Table 105. Takeda Pharmaceutical Company Endometriosis Drugs Product Table 106. Takeda Pharmaceutical Company Revenue in Endometriosis Drugs Business (2018-2023) & (US$ Million) Table 107. Takeda Pharmaceutical Company Recent Development Table 108. ValiRx Company Detail Table 109. ValiRx Business Overview Table 110. ValiRx Endometriosis Drugs Product Table 111. ValiRx Revenue in Endometriosis Drugs Business (2018-2023) & (US$ Million) Table 112. ValiRx Recent Development Table 113. Research Programs/Design for This Report Table 114. Key Data Information from Secondary Sources Table 115. Key Data Information from Primary Sources List of Figures Figure 1. Global Endometriosis Drugs Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global Endometriosis Drugs Market Share by Type: 2022 VS 2029 Figure 3. Hormonal Therapy Features Figure 4. Add-back Medication Features Figure 5. Progestogens Features Figure 6. Chinese Herbs Features Figure 7. Global Endometriosis Drugs Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 8. Global Endometriosis Drugs Market Share by Application: 2022 VS 2029 Figure 9. Hospitals Case Studies Figure 10. Clinics Case Studies Figure 11. Research Institutes Case Studies Figure 12. Endometriosis Drugs Report Years Considered Figure 13. Global Endometriosis Drugs Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 14. Global Endometriosis Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 15. Global Endometriosis Drugs Market Share by Region: 2022 VS 2029 Figure 16. Global Endometriosis Drugs Market Share by Players in 2022 Figure 17. Global Top Endometriosis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endometriosis Drugs as of 2022) Figure 18. The Top 10 and 5 Players Market Share by Endometriosis Drugs Revenue in 2022 Figure 19. North America Endometriosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 20. North America Endometriosis Drugs Market Share by Country (2018-2029) Figure 21. United States Endometriosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 22. Canada Endometriosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 23. Europe Endometriosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 24. Europe Endometriosis Drugs Market Share by Country (2018-2029) Figure 25. Germany Endometriosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 26. France Endometriosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 27. U.K. Endometriosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. Italy Endometriosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. Russia Endometriosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Nordic Countries Endometriosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 31. Asia-Pacific Endometriosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. Asia-Pacific Endometriosis Drugs Market Share by Region (2018-2029) Figure 33. China Endometriosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 34. Japan Endometriosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 35. South Korea Endometriosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. Southeast Asia Endometriosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. India Endometriosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. Australia Endometriosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 39. Latin America Endometriosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. Latin America Endometriosis Drugs Market Share by Country (2018-2029) Figure 41. Mexico Endometriosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 42. Brazil Endometriosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 43. Middle East & Africa Endometriosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. Middle East & Africa Endometriosis Drugs Market Share by Country (2018-2029) Figure 45. Turkey Endometriosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 46. Saudi Arabia Endometriosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 47. AbbVie Revenue Growth Rate in Endometriosis Drugs Business (2018-2023) Figure 48. Astellas Pharma Revenue Growth Rate in Endometriosis Drugs Business (2018-2023) Figure 49. AstraZeneca Revenue Growth Rate in Endometriosis Drugs Business (2018-2023) Figure 50. Debiopharm Group Revenue Growth Rate in Endometriosis Drugs Business (2018-2023) Figure 51. Evotec Revenue Growth Rate in Endometriosis Drugs Business (2018-2023) Figure 52. Kissei Pharmaceutical Revenue Growth Rate in Endometriosis Drugs Business (2018-2023) Figure 53. Neurocrine Biosciences Revenue Growth Rate in Endometriosis Drugs Business (2018-2023) Figure 54. ObsEva Revenue Growth Rate in Endometriosis Drugs Business (2018-2023) Figure 55. Pfizer Revenue Growth Rate in Endometriosis Drugs Business (2018-2023) Figure 56. Repros Therapeutics Revenue Growth Rate in Endometriosis Drugs Business (2018-2023) Figure 57. Roivant Sciences Revenue Growth Rate in Endometriosis Drugs Business (2018-2023) Figure 58. Takeda Pharmaceutical Company Revenue Growth Rate in Endometriosis Drugs Business (2018-2023) Figure 59. ValiRx Revenue Growth Rate in Endometriosis Drugs Business (2018-2023) Figure 60. Bottom-up and Top-down Approaches for This Report Figure 61. Data Triangulation Figure 62. Key Executives Interviewed
AbbVie Astellas Pharma AstraZeneca Debiopharm Group Evotec Kissei Pharmaceutical Neurocrine Biosciences ObsEva Pfizer Repros Therapeutics Roivant Sciences Takeda Pharmaceutical Company ValiRx
This report aims to provide a comprehensive presentation of the global market for Endovascular Ab ... Read More
This report aims to provide a comprehensive presentation of the global market for Energy Efficien ... Read More
This report aims to provide a comprehensive presentation of the global market for Energy Manageme ... Read More
This report aims to provide a comprehensive presentation of the global market for Energy Manageme ... Read More